YTS104 Cells injection
IIT2023020
Phase 1 mab active
Quick answer
YTS104 Cells injection for Relapsed or Refractory Multiple Myeloma is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Relapsed or Refractory Multiple Myeloma
- Phase
- Phase 1
- Modality
- mab
- Status
- active